Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 4
2006 2
2007 2
2008 4
2009 6
2010 5
2011 6
2012 2
2013 5
2014 5
2015 4
2016 4
2017 5
2018 2
2019 5
2020 1
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
Lécuyer D, Nardacci R, Tannous D, Gutierrez-Mateyron E, Deva Nathan A, Subra F, Di Primio C, Quaranta P, Petit V, Richetta C, Mostefa-Kara A, Del Nonno F, Falasca L, Marlin R, Maisonnasse P, Delahousse J, Pascaud J, Deprez E, Naigeon M, Chaput N, Paci A, Saada V, Ghez D, Mariette X, Costa M, Pistello M, Allouch A, Delelis O, Piacentini M, Le Grand R, Perfettini JL. Lécuyer D, et al. Among authors: delelis o. Front Immunol. 2023 Oct 18;14:1270081. doi: 10.3389/fimmu.2023.1270081. eCollection 2023. Front Immunol. 2023. PMID: 37920468 Free PMC article.
5-Nitro-3-(2-(4-phenylthiazol-2-yl)hydrazineylidene)indolin-2-one derivatives inhibit HIV-1 replication by a multitarget mechanism of action.
Corona A, Meleddu R, Delelis O, Subra F, Cottiglia F, Esposito F, Distinto S, Maccioni E, Tramontano E. Corona A, et al. Among authors: delelis o. Front Cell Infect Microbiol. 2023 Jun 23;13:1193280. doi: 10.3389/fcimb.2023.1193280. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37424782 Free PMC article.
Differential activation of human neutrophils by SARS-CoV-2 variants of concern.
Lebourgeois S, David A, Chenane HR, Granger V, Menidjel R, Fidouh N, Noël B, Delelis O, Richetta C, Charpentier C, Chollet-Martin S, Descamps D, Visseaux B, de Chaisemartin L. Lebourgeois S, et al. Among authors: delelis o. Front Immunol. 2022 Oct 27;13:1010140. doi: 10.3389/fimmu.2022.1010140. eCollection 2022. Front Immunol. 2022. PMID: 36389717 Free PMC article.
The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC-II molecules.
Sarango G, Richetta C, Pereira M, Kumari A, Ghosh M, Bertrand L, Pionneau C, Le Gall M, Grégoire S, Jeger-Madiot R, Rosoy E, Subra F, Delelis O, Faure M, Esclatine A, Graff-Dubois S, Stevanović S, Manoury B, Ramirez BC, Moris A. Sarango G, et al. Among authors: delelis o. EMBO Rep. 2022 Dec 6;23(12):e55470. doi: 10.15252/embr.202255470. Epub 2022 Oct 10. EMBO Rep. 2022. PMID: 36215666 Free PMC article.
Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces.
Lapaillerie D, Charlier C, Guyonnet-Dupérat V, Murigneux E, Fernandes HS, Martins FG, Magalhães RP, Vieira TF, Richetta C, Subra F, Lebourgeois S, Charpentier C, Descamps D, Visseaux B, Weigel P, Favereaux A, Beauvineau C, Buron F, Teulade-Fichou MP, Routier S, Gallois-Montbrun S, Meertens L, Delelis O, Sousa SF, Parissi V. Lapaillerie D, et al. Among authors: delelis o. Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0008322. doi: 10.1128/aac.00083-22. Epub 2022 Jul 5. Antimicrob Agents Chemother. 2022. PMID: 35861550 Free PMC article.
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
Richetta C, Subra F, Malet I, Leh H, Charpentier C, Corona A, Collin G, Descamps D, Deprez E, Parissi V, Calvez V, Tramontano E, Marcelin AG, Delelis O. Richetta C, et al. Among authors: delelis o. J Virol. 2022 Jul 27;96(14):e0067622. doi: 10.1128/jvi.00676-22. Epub 2022 Jun 27. J Virol. 2022. PMID: 35758669 Free PMC article.
Discovery, SAR study and ADME properties of methyl 4-amino-3-cyano-1-(2-benzyloxyphenyl)-1H-pyrazole-5-carboxylate as an HIV-1 replication inhibitor.
Fichez J, Soulie C, Le Corre L, Sayon S, Priet S, Alvarez K, Delelis O, Gizzi P, Prestat G, Gravier-Pelletier C, Marcelin AG, Calvez V, Busca P. Fichez J, et al. Among authors: delelis o. RSC Med Chem. 2020 Apr 27;11(5):577-582. doi: 10.1039/d0md00025f. eCollection 2020 May 1. RSC Med Chem. 2020. PMID: 33479659 Free PMC article.
HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry.
Paoletti A, Allouch A, Caillet M, Saïdi H, Subra F, Nardacci R, Wu Q, Muradova Z, Voisin L, Raza SQ, Law F, Thoreau M, Dakhli H, Delelis O, Poirier-Beaudouin B, Dereuddre-Bosquet N, Le Grand R, Lambotte O, Saez-Cirion A, Pancino G, Ojcius DM, Solary E, Deutsch E, Piacentini M, Gougeon ML, Kroemer G, Perfettini JL. Paoletti A, et al. Among authors: delelis o. Cell Rep. 2019 Sep 24;28(13):3381-3394.e7. doi: 10.1016/j.celrep.2019.02.095. Cell Rep. 2019. PMID: 31553908 Free article.
66 results